The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1341
Preservation of Ovarian Function During Chemotherapy
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Chemotherapy can result in premature menopause and infertility in young women. Pretreatment fertility counseling followed by appropriate action may prevent some of these undesirable consequences.1,2

FERTILITY PRESERVATION — Embryo cryopreservation after in vitro fertilization remains the standard of care for fertility preservation in women, but oocyte cryopreservation is also used. Ovarian tissue freezing for later transplantation, while available at some centers, is experimental, and data on its efficacy are limited to case reports.3-5 All of these techniques are invasive, and none would prevent premature menopause, which can lead to early osteoporosis and coronary artery disease.

OVARIAN SUPPRESSION — Two small observational studies suggest that oral contraceptive pills may preserve ovarian function,6,7 ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Preservation of Ovarian Function During Chemotherapy
Article code: 1341b
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian